The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate

July 15, 2022 at 09:03 AM EDT

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NexImmune ReceivesIND ...